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METHOD AND SYSTEM FOR

NON - INVASIVE OPTICAL BLOOD GLUCOSE
DETECTION UTILIZING SPECTRAL DATA

ANALYSIS
CROSS -REFERENCE TO RELATED

form SMBG more frequently and have improved quality of
life with a non - invasive blood glucose monitoring device .
There exist a number of non - invasive approaches for

5 blood glucose determination . One technique of non-invasive

APPLICATION

blood chemical detection involves collecting and analyzing
light spectra data .

Extracting information about blood characteristics, such
application Ser. No. 12 /425 ,535 , filed Apr. 17 , 2009, which 10 from spectroscopy, is a complex problem due to the presence
This application is a divisional of prior U . S . patent

as glucose concentration from spectral or other data obtained

is hereby incorporated herein by reference in its entirety , and
also claims priority to U .S . Provisional Patent Application

of components (e . g ., skin , fat, muscle , bone, interstitial
fluid ) other than blood in the area that is being sensed . Such

Ser. No. 61/ 055, 303 , filed on May 22 , 2008 , the disclosure

other components can influence these signals in such a way

ofwhich is incorporated herein by reference, and also claims as to alter the reading. In particular, the resulting signal may
priority to U . S . Provisional Patent Application Ser. No . 15 be much larger in magnitude than the portion of the signal
61/089 , 152 , filed on Aug . 15 , 2008 , the disclosure of which
that corresponds to blood , and therefore limits the ability to
is incorporated herein by reference .
accurately extract blood characteristics information .
The present invention is directed to overcoming one or
BACKGROUND OF THE INVENTION
more of the problems set forth above .
20
Diabetes is a chronic disease that , when not controlled ,
SUMMARY OF INVENTION
over time leads to serious damage to many of the body 's
systems, including the nerves , blood vessels , eyes, kidneys
In an aspect of the present invention , a system for
and heart. The National Institute of Diabetes and Digestive
detecting glucose in a biological sample is disclosed . This
and Kidney Diseases (NIDDK ) estimates that 23 .6 million 25 system includes at least one light source configured to strike
people , or 7 .8 percent of the population in the United States,
a target area of a sample , at least one light detector, which
had diabetes in 2007. Globally, the World Health Organiza - includes a preamplifier having a feedback resistor, posi

tion (WHO ) estimates that more than 180 million people tioned to receive light from the at least one light source and
to generate an output signal, having a time dependent
million by 2030 , with 30 .3 million in the United States . 30 current, which is indicative of the power of light detected ,
According to the WHO , an estimated 1. 1 million people died and a processor configured to receive the output signal from

have diabetes, a number they expect to increase to 366

from diabetes in 2005 . They project that diabetes deaths will the at least one light detector and based on the received
increase by more than 50 % between 2006 and 2015 overall output signal, calculate the attenuance attributable to blood
and by more than 80 % in upper -middle income countries
in a sample present in the target area and eliminate effect of
The economic burden from diabetes for individuals and 35 uncertainty caused by temperature dependent detector
society as a whole is substantial. According to the American
response of the at least one light detector, and based on the

Diabetes Association, the total annual economic cost of

calculated attenuance, determine a blood glucose level asso

$ 8 billion more each year .

method includes utilizing at least one light source configured

A vital element of diabetes management is the selfmonitoring of blood glucose ( SMBG ) concentration by
diabetics in the home environment. By testing blood glucose

to strike a target area of a sample utilizing at least one light
detector, which includes a preamplifier having a feedback
resistor, positioned to receive light from the at least one light

negative health outcomes. In fact, the Diabetes Control and

detected , and utilizing a processor that receives the output

diabetes was estimated to be $ 174 billion in the United
ciated with a sample present in the target area .
States in 2007. This is an increase of $ 42 billion since 2002.
In yet another aspect of the present invention , a method
This 32 % increase means the dollar amount has risen over 40 for detecting glucose in a biological sample is disclosed . The

levels often , diabetics can better manage medication , diet, 45 source and generating an output signal, having a time
and exercise to maintain control and prevent the long -term
dependent current, which is indicative of the power of light

Complications Trial (DCCT), which followed 1 ,441 diabetsignal from the at least one light detector and based on the
ics for several years , showed that those following an inten - received output signal, calculating the attenuance attribut
sive -control program with multiple blood sugar tests each 50 able to blood in a sample present in the target area and
day , as compared with the standard -treatment group , had
eliminating effect of uncertainty caused by temperature
only one- fourth as many people develop diabetic eye dis dependent detector response of the at least one lightdetector,
ease , half as many develop kidney disease , one-third as
and based on the calculated attenuance , determining a blood

many develop nerve disease , and far fewer people who
glucose level associated with a sample present in the target
already had early forms of these three complications got 55 area .
worse .

These are merely some of the innumerable aspects of the

However , currentmonitoring techniques discourage regu -

present invention and should not be deemed an all - inclusive

lar use due to the inconvenient and painful nature of drawing
blood through the skin prior to analysis, which causes many

listing of the innumerable aspects associated with the pres
e nt invention .

diabetics to not be as diligent as they should be for good 60

blood glucose control. As a result, non - invasive measure

BRIEF DESCRIPTION OF THE DRAWINGS

ment of glucose concentration is a desirable and beneficial

development for the management of diabetes . A non - inva
For a better understanding of the present invention , ref
sive monitor will make testing multiple times each day
erence may be made to accompanying drawings , in which :
pain -free and more palatable for children with diabetes. 65 FIG . 1 illustrates a plot of a pulse wave corresponding to

According to a study published in 2005 (J. Wagner, C .

Malchoff, and G . Abbott, Diabetes Technology & Therapeu -

light absorption of arterial blood , according to exemplary

embodiments ;
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FIG . 2 illustrates an exemplary system for obtaining

is absorbed and scattered , i.e., attenuated , by the blood can
be detected based on the peaks and valleys of the plot 102.

spectral data ;

FIG . 3 illustrates a plot of A (t), calculated according to
Equation (9 ) using data in FIG . 1 ; and

Assuming that the peak of the cyclic photocurrent gen
erated by the light-sensing device is Ip, the adjacent valley

FIG . 4 is a basic illustrative schematic of a preamplifier 5 of the cyclic photocurrent is ly , and the photocurrent gen
circuit that converts photocurrent into voltage prior to digierated by the light- sensing device without a human finger is
Io , the transmittances corresponding to the peak and valley
tization .
photocurrents can be defined as :
DETAILED DESCRIPTION OF THE
10
INVENTION

Ty =

Tv =

In the following detailed description , numerous exem

plary specific details are set forth in order to provide a

and

thorough understanding of the invention . However , it will be
understood by those skilled in the art that the present 15

Ip

invention may be practiced without these specific details, or

with various modifications of the details . In other instances ,

well known methods, procedures, and components have not
been described in detail so as not to obscure the present
invention .

The corresponding peak and valley absorbance are :
20

Optical spectroscopy can be used to determine the amount
of light absorbed and scattered , i.e ., attenuated , by a bio
logical sample such as a human finger. By measuring the
amount of light absorbed by the sample , it is possible to

determine glucose , cholesterol, and hemoglobin levels of a 25

subject non - invasively . Fingertip measurements are usually
the fingertip and because of the conversion of arterial blood
preferred because of the large concentration of capillaries in

Ap = - log (Tv )
and

Ap= - log (Tp)
(4 )
TThe difference between Ay and Ap represents the light

absorption and scattering by the blood in the finger, exclud
ing non - blood constituents :

into venous blood that occurs in the fingertip . However, the

techniques of the present invention are not limited to use 30

with a fingertip . For example , the biological sample could be

AA = Ay – Ap= log ( s)

a human earlobe.

When light is transmitted through a biological sample,

such as a human finger, the light is attenuated by various

As can be seen in the algorithm shown in Equation (5 ),

components of the finger including skin , muscle , bone, fat, 35 AA does not depend on 1o . Thus , calculating AA does not
interstitial fluid and blood . It has been observed , however, require a determination of the current generated by the

that light attenuation by a human finger exhibits a small

cyclic pattern that corresponds to a heartbeat . It is believed
that this cyclic pattern will be present in measurements of

light-sensing device without a sample .Monitoring the pho

tocurrent corresponding to light power transmitted through
a sample is sufficient to calculate AA .

many other human body parts , the earlobe being one of 40 FIG . 2 depicts a simplified block diagram of an exemplary
m
many
examples .
apparatus for use in an exemplary embodiment. Optical
FIG . 1 depicts a plot 102 of a detector photocurrent, I , (t), measurement system , which is generally indicated by
that corresponds to the power of light received by a detector numeral 200 , uses the “ pulsatile ” concept for determining an
after the light has passed through a subject's finger. As can amount of light absorbed and scattered solely by the blood
be seen , the detector photocurrent exhibits a cyclic pattern . 45 in a sample ( a human finger in this exemplary embodiment).

This cyclic pattern is due to the subject's heartbeat , which
cyclically increases and decreases the quantity of blood in

power source 201, such as a battery , provides power to a
light source 202 that generates a plurality of light beams

the subject's capillaries (or other structures ). Although the

204 , 206 , 208 , 210 that are directed toward the top of the

magnitude of the cyclic pattern is small in comparison to the

finger of a subject. In an exemplary embodiment, each of the

total photocurrent generated by the detector , considerable 50 light beams 204 , 206 , 208 , 210 have the same wavelength or

information can be extracted from the cyclic pattern of the

a different wavelength range , typically within 800 nm to

plot 102 . For example , assuming that the person ' s heart rate
is sixty beats per minute , the time between the start of any

1600 nm . Although the optical measurement system 200 is
described herein as generating four (4 ) light beams, it is

pulse beat and the end of that pulse beat is one second

contemplated that the light source 202 can be altered to

During this one-second period , the photocurrent will have a 55 generate fewer light beams or additional light beamsin other

maximum or peak reading 104 and minimum or valley

reading 106 . The peak reading 104 of the plot corresponds
to when there is a minimum amount of blood in the
capillaries , and the valley reading 106 corresponds to when

embodiments .

A first aperture 212 ensures that the light beams 204 , 206 ,
208 , 210 strike a target area of the finger. A second aperture
214 ensures that the portion of the light beams that are

there is a maximum amount of blood in the capillaries . By 60 transmitted through the finger strike a lens 216 . Light beams

using information provided by the peak and valley of the

204 , 206 , 208 , 210 are attenuated by the finger and compo

cyclic plot, the optical absorption and scattering by major
finger constituents that are not in the capillaries, such as
skin , fat, bones, muscle and interstitial fluids, are excluded
These major constituents that are not in the capillaries are 65

nents of the optical measurement system 200 , and , thus ,
attenuated light beams 218 , 220 , 222 , 224 are emitted from
the finger. The attenuated light beams 218 , 220, 222 , 224
strike the lens 216 , and the lens 216 collects the attenuated

excluded because they are not likely to change during the
time interval of one heartbeat. In other words , the light that

light beams 218 , 220 , 222 , 224 so that they impinge more
efficiently on a detector block 226 .
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The detector block 226 is positioned directly under the
lens 216 and comprises a plurality of light- sensing devices
(LSD ) 228, 230, 232 , 234 such as an array of photodiodes.
According to one aspect of the optical measurement system

Improving S /N Ratio by Standard Deviation
The time dependent detector photocurrent output, ID (t),
shown in FIG . 1 can be expressed as the sum of a small time
dependent cyclic photocurrent Al(t), corresponding to the

200 , each of the light- sensing devices 228 , 230 , 232 , 234 5 heartbeat, a noise current n (t), and a constant baseline
detects a specific wavelength of light as defined by corre - photocurrent lo :

sponding interference filters (IF ) 236 , 238 , 240 , 242 , respec

tively . The interference filter transmits one or more spectral

bands or lines of light, and blocks others .
Each of the light -sensing devices 228 , 230 , 232 , 2341010
generates a corresponding photocurrent signal that is pro

portional to the power of the light received by the particular
light sensing device. The photocurrent signal generated by
the photodiode can be converted to another form of signal, 15
such as an analog voltage signal or a digital signal. A 15

processor 243 is coupled to the detector block 226 and is

configured to calculate the change of photocurrent signals
244, 246 , 248 , 250 .

According to one aspect, the processor 243 executes an 20
algorithm such as shown in the Equation (5 ) to calculate the

1o (t)=15 + A1(t)+n (t)
The above Equation can be re-arranged as :
Id (t)
12

= l +

(7)

Al(t) + n (t)
13

Applying common logarithm to both side of the Equation
(8 ), one obtains:

Alo)= log['10 ]= log(1+ A160)+ (O)
Al(t ) + n ( t)
IB

A (t) =

(9 )

change in the light absorption (AA ) solely caused by the

blood in the finger. Thereafter, this quantitative calculation
of light absorption of the blood can be used to determine a

FIG . 3 , which is generally indicated by numeral 300 ,

shows a typical A?t) plot 302 , calculated according to

characteristic of the blood. For example, by comparing the 25 Equation (9 ) using data in FIG . 1 . For a pulse function A (t)
calculated light absorption value to predetermined values
shown in FIG . 3 , the following key relationship exists during
corresponding to different glucose levels stored in a memory the time interval of one heartbeat:
(not shown ), a blood - glucose level of the subject can be
( 10 )
O[A(t)]=kA4
determined .

A difficulty associated with the finger based pulsatile 30 in which o [A (t) ] is the Standard Deviation of A (t), and k is
a proportional constant.
Considering the fact that lg is a constant and o? (log 1B )= 0 ,
because the amplitude of cyclic pattern (i.e ., the difference
detection methodology is low signal-to -noise (S /N ) ratio ,

between peak and valley ) is typically 1 % - 2 % of the total
photocurrent generated by the light power transmitted

one obtains:

( 12)

0 [A ( )]= o [ log ID (0) ]

through the finger . To obtain a S /N ratio of 100 : 1 in the 35 Therefore , the peak -to -valley height of the A?t) plot
determination of AA , the baseline noise of the device being during
of one heartbeat can be obtained
used to measure the light absorption by the finger should not directly thefromtimetheinterval
standard deviation of the logarithm of
be larger than 3 .0x10 - 5 in absorbance (peak to peak ), within
Io (t):
a 10 Hz bandwidth .
However, a 3 .0x10 - 9 absorbance (peak to peak ) baseline 40
noise level within a 10 Hz bandwidth is difficult to obtain

with the low light power levels that are used by some

AA =

o [A (1)] o?logd (0) ]

(13)

=

battery -powered hand held non - invasive blood chemical
measurement devices . One solution involves data averaging.
To increase the S /N ratio , the averaged value of AA , as 45 A major advantage of Equation ( 13 ) is that high S /N ratio
defined by the Equation below , is used in further calculation can be achieved within short data acquisition time (approxi
mately one second ), as explained below .
to extract blood glucose concentration :
In a finger based pulsatile measurement depicted by FIG .
2 , the value of the sum , Al(t)+ n (t) is typically less than 2 %
(6 ) 50 of the large constant baseline photocurrent Ib . Therefore ,

AA = AA;

In Equation (6 ), M is the number ofheartbeats during the

time interval of the pulsatile measurement. However, this 55
approach requires long data acquisition time, due to the fact
that the rate of heartbeat is in the order of one per second .

For example , 25 seconds would be needed for increasing the
S /N ratio by a factor of five, and 100 seconds would be

Equation (9 ) can be approximated as:

VON boll (l) In101 Al(t)+ n(t)

A (t ) = 1

(14 )

B

Similarly , the standard deviation of A (t) can be approxi

mated as :

needed for increasing the S / N ratio by a factor of ten . In 60

comparison , current commercial blood drawing glucose
meters can determine blood glucose level within 5 seconds.

1 Ve [All ] +?n( )]
o [A(1)] ?| In10
18

(15 )

Furthermore, long detection time will significantly increase
drift , device temperature change, etc . Thus, there is a need 65 Equation (15 ) demonstrates great noise reduction power
for new techniques to measure blood glucose levels quickly of Equation (13 ). For example , for a relatively high baseline

measurement errors due to finger movement, light power

and accurately.

noise with the ratio
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p =

c [ (t)]

Q :( C , T ) =

o [logAl(0 ] = 0.1(or 10 % ),

the contribution to o [ A (t) ] from the baseline noise n (t) is
estimated to be less than 0.005 (or 0 .5 % ), corresponding to

o [ log /p (^ ;, )]/k

AAA )

=

o [log p (1 ;, t)]

(18)

§ 44(1;) Šo[log p( ;, )]/k i o?log/p();,1)]

As shown by Equation ( 18 ), the constant k is cancelled

an increase in S /N ratio by a factor of 20 without increasing

and o?log Iy (t) ] will be used in further regression analysis to

detection time. As such , dramatic noise reduction can be

establish correlation between the optical measurement and

obtained without increasing the data acquisition time, and a 10 blood glucose level. This is possible because data are taken
finger based pulsatile measurement can be completed within simultaneously from all detection channels .

the time interval of one heartbeat (which is approximately
1 in determination of AA can be satisfied using an optical
system with a baseline noise of about 6 .0x10 -4 absorbance
(peak to peak ) within a 10 Hz bandwidth . It should be

A correlation between optical measurement and blood

one second ), and the requirement for the S / N ratio of 100 to

glucose concentration can be established according to the

following Equation :

15

pointed out that when the baseline noise of an optical system

Copricat = ;(7)QQ/:(CT
C, 1))

is dominated by shot noise due to low light illumination

optical =

power, a noise reduction by a factor of 20 equals an
increasing in light illumination power by a factor of
202 = 400 .

( 19 )

in which Copticai is the blood glucose concentration predicted
by the optical measurement, Q .(CT) is defined by Equations
(17 ) and (18 ), and a ( T ) is the temperature dependent regres
sion coefficient corresponding to wavelength z. The values

This ability of obtaining higher S /N ratio within the very

short data acquisition time, e.g ., less than one second , will
finger movement, temperature change , and light power drift
a ;( T ) can be extracted using proper statistics methods such
during the measurement, and therefore dramatically improve 25 of
as Partial Least Squares ( PLS ) regression .
the accuracy and reproducibility of the pulsatile detection
Equation ( 19 ) represents ideal cases when large number
methodology
significantly reduce detection error caused by factors such as

of calibrations can be made at different finger temperatures.

Furthermore , the value of k does not change with wave
length , because transmitted lights at all wavelengths have

In reality, frequently only a limited number of calibrations

be made (e.g ., 15 to 20 ), and each may be taken at a
identical pulse shape due to the heartbeat. As a result, the 30 can
different finger temperature . Under this condition , the finger
constant k will be cancelled in data normalization discussed
can be treated as an independent variable , and
in next section , and o [ log ID (t) ] will be used in further temperature
the above Equation can be approximated as :
regression analysis to establish correlation between the
optical measurement and blood glucose level. This will 35
os
greatly simplify the data analysis process since o?log I , (t )]

involves only two standard math functions available in most

Coptical =

popular spreadsheet programs such as Microsoft EXCEL® .
EXCEL® is a federally registered trademark of Microsoft

b ; Q :(C , T ) + nT

(20)

Corporation , having a place of business at One Microsoft an40 in which b ; is the temperature independent regression coef

Way, Redmond , Wash . 98052 -6399 .

ficient corresponding to wavelength ;, and n is the regres

Normalization

sion coefficient for the finger temperature . The values of b ;
and that of n can be extracted using proper statistics methods

At each wavelength ài, the absorption AA ( ;) is linked to
the increase of amount of blood (AB ) in the optical sensing
area of the fingertip due to the heartbeat by the following
Equation :

such as Partial Least Squares (PLS) regression .
Alternatively, the uncertainty from the variable AB can be
cancelled by introducing a ratio factor Y , at wavelength àz:

(16)

A4(A ) =E( C,2 , T)AB

in which e (C , , T ) is the absorption / scattering coefficient of
blood at wavelength d?, finger temperature T, and blood

AA (1;) _ E(C, 1;, T) _ o [log/p(11, 1)]
(21)
glucose concentration C . It is well understood that the 30
Ha? ! " AA(A ;) – (C , 1 ;, T ) – o [log/p (1 ;, t)]'
variable AB differs from person to person , and may even
change from day to day for the same person .
The uncertainty from the variable AB can be cancelled
by
incelled
by inin which j can be any number from 1 to N , assuming that the
introducing the normalization factor Q :(C , T) at each
wave
wave
55 device collects signal at all N wavelengths .
length ;, as defined by the Equation below :
Similar to the normalization algorithm discussed before ,

e established"acasurement andbid before,

a correlation between optical measurement and blood glu

Qi( C , T ) =

AA (X )

E (C , 1 ;, T )

AA(1;) Š &(C,1;, T)

cose level can be established according to the following

( 17 )

Equation :
60

(22)

Coptical =
fi (T ) Y;j(C , T )
in which N is total number of wavelength employed . Pref
i# j
erably, N typically ranges from twenty to thirty .
Based on Equations (13 ) and ( 17 ), Q :(C , T ) is linked to the 65
detector photocurrent at each wavelength vi, ID (art), by the in which Copticai is the blood glucose concentration predicted
following Equation :
by the opticalmeasurement, Y , (C , T ) is defined by Equation
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(21 ), and f;( T ) is the temperature dependent regression FIG . 4 shows the schematic circuit diagram of a typical
coefficient corresponding to wavelength à ;. The value of preamplifier, which is generally indicated by numeral 400.
f;( T ) can be obtained using statistics methods such as Partial
The output voltage 412 of ith preamplifier 400 , in cou
Least Squares (PLS) regression .
pling with ith photodiode detector 408 , can be expressed as :
Equation (22 ) represents ideal cases when large number 5
Vi(t)= r;15 ( t)= Ro; [1 +%:(Tri(t)- 25° C.)]]] () int)
of calibration can be made at different finger temperatures .
In reality, frequently only limited number of calibration can
In the above Equation (27), Ro; is the resistance value of
be made (e.g ., 15 to 20 ), and each may be taken at a different feedback resistor 402 for ith preamplifier at 25° C ., Xi is the
finger temperature . Under this condition , the finger tempera - temperature coefficient of the resistor, and Tri(t ) is the
ture can be treated as an independent variable, and the above 10 temperature of the resistor. Applying common logarithm to
Equation can be approximated as :
both side of the Equation ( 27 ), one obtains:
log V:(t) = log Rio + log [ 1 + X:(Tri(t) - 25° C.)]+ log

Copicot= ?MY,(C,1)+ BT

(23)

iuj

Iph ,t)

(28)

15 Considering the fact that Roi is a constant and that the
resistor temperature Tri (t) does not change during the very
short data acquisition time interval of approximately one

one obtains.:
widt ,, vivum
in which h ; is the temperature independent regression coef second
ficient corresponding to wavelength ;, and ß is the regres
(29)
O [log V: ( ]= o [log 10 (1 ;,t)]
sion coefficient for the finger temperature . The values of h ; 20 Substituting Equation (26 ) into Equation (29 ), one
and that of ß can be extracted using proper statistics methods
obtains :
such as Partial Least Squares (PLS) regression .
avice
Elimination of the Effect of Temperature Dependent Device
(30)
O [log V;()]=o [log P (),;t)]
Response

It is well understood that the detector sensitivity of a 25 As such , the uncertainty caused by resistor temperature Ty(t )

silicon photodiode detector is a function of wavelength and is eliminated .
Under the voltage detection mode, the normalization
temperature. For the device configuration shown in FIG . 2 ,
which is generally indicated by numeral 200 , the light power factor in Equation (18 ) can be expressed as :
received by ith silicon diode detector, corresponding to
wavelength ;, is converted into a photocurrent according to 30
( 31)
the following Equation :
Q:(C , 1) = o [logV (0)]

Id (),;,t)= P () ,t)S0 (2 )(1+ y(2 )(TD :(t)- 25° C .)]

I o[logy:()]

(24 )

In the above Equation (24 ), P ( ;,t) is the light power

received by the detector, Sca ) is the photosensitivity of the ~
Themathematic correlation between optical measurement
detector at wavelength ; and 25° C ., y (a ) is the temperature
and blood glucose concentration can then be established

coefficient of the photosensitivity at wavelength ài, and
T ) ; (t ) is the temperature of ith photodiode detector. The
temperature coefficient ya :) varies with the wavelength . For

according to Equation (19 ) or Equation ( 20 ), under corre
Similarly, the ratio factor defined by Equation (21) can be

sponding calibration conditions .

example , for Hamamatsu S 1337 series photodiode detec - to expressed as :

tors , yaz) ranges from near zero at 900 nm to over 1 .0 % /º
C . at 1100 nm . This imposes a potential problem for the
device configuration show in FIG . 2 , because it is very

difficult to keep temperature of each individual diode detec

o [logV ;(d)]

Y;j(C , T) = o?logV;(0)]

(32)

tor constant in a handheld device used by a person with
diabetes under a normal household office environment.
mathematic correlation between optical measurement
This uncertainty due to the detector temperature Tdi(t) andTheblood
concentration can then be established
can be eliminated using the algorithm shown by Equations according toglucose
Equation
( 22 ) or Equation ( 23 ), under corre
( 12 ) and ( 13 ). Applying common logarithm on both sides of 50 sponding calibration conditions
. The schematic circuit dia
the Equation (24 ), one obtains:
gram of a typical preamplifier 400 also includes a feedback
capacitor 404 , an operational amplifier 406 , and a ground
log 10 () ;,1)= log P (9j, )+ log S. ( ;)+log [ 1 +
Y(a ;)( TDi(t)- 25° C.)]

(25 )

connection 410 .
Digitization

outr 412 from the preamplifier 400 is
Considering the fact that s . ) is a constantt and
that
andduring
that 5555 The voltage output
detector temperature TDi(t) remains almost constant
usually digitized using an analog -to -digital convertor
the very short data acquisition time interval of approxi ( ADC ). The digitized signal is then sent to a computer for

mately one second , one obtains :
data analysis. The output of ith ADC , in communication with
ith preamplifier that is in coupling with ith photodiode 408
o [ log ID ( 1,1)]= o [ log P (2,1,1)]
(20) 60 collecting light power at wavelength l?, can be expressed by
As such , the uncertainty caused by detector temperature the following Equation :
Toi(t) is eliminated by the use of this standard deviation
(33)
(ADC ) = (ADC )o:+ G {[ Id (237)+ IDark,j]R,+ A0;}
methodology.
Voltage Detection Mode
In the above Equation (33 ), (ADC )o; is the offset of ith
In the device configuration shown in FIG . 2 , the photo - 65 ADC , G ; is the nominalADC Gain used during the detection ,
current of ith photodiode detector IDQ ;,t) is typically con - ID ;,t) is the photocurrent of ith photodiode detector, IDark ,i
verted into a voltage using a preamplifier before digitization . is the dark current of ith photodiode detector, R =
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Roj [ 1 + X :( Tri(t) - 25° C .)]] is the resistance of feedback resis tor of ith preamplifier , and Ao; is the offset of ith preampli fier.
The contribution of the three factors, (ADC )o , IDark.i, and

Ao ; can be removed by carrying out a dark measurement 5

with the light source turned off right before or after the

deemed to be covered by the invention , which is limited only
by the claims that follow . It should be understood that the
embodiments disclosed herein include any and all combi
nations of features described in any of the dependent claims.
The invention claimed is :

corresponding finger measurement. When the light source is

1. A system for detecting glucose in a biological sample,

comprising:
turned off, the above Equation (33 ) becomes:
one lightbeam generating structure generating one
(34) 10 at least
(ADC) Dark,i= (ADC)o:+ G ;(IDark,;R;+ A01)
or more light beams having a wavelength in a range
The difference between the two above Equations (33 ) and
between 800 nm and 1600 nm to strike a target area of
(34 ) reflects ADC output corresponding to the photocurrent:
a biological sample ;
at least one photocurrent signal generating light detector,
(35)
A (ADC ),F (ADC);- (ADC)Dark,; =G ;]] ();t)R ;
which includes a preamplifier having a feedback resis
Applying common logarithm to both side of the Equation 15
(35 ), one obtains:
(36 )
log A (ADC) = log Gi+ log Ip () ;t)+ log R ;

G ; and R , can be considered as constants as long as the

time interval between the finger measurement and the dark 20

measurement is short. As such , one obtains:

o [log A (ADC);]= o [ log ID ( ;,1) ]

(37)

Substituting Equation (26 ) into Equation (37 ) ,one further
obtains:

25

(38 )
o [ log A ( ADC);]= o [log P (),int)]
Based on Equation (37 ), the normalization factor defined
by Equation (18 ) can be expressed as:

source and to generate an output photocurrent signal,
having a time dependent current, which is indicative of

the power of light detected ;
wherein the preamplifier having a feedback resistor is
configured to convert the time dependent current into a
time dependent voltage signal; and

a light absorbance change determining algorithm imple
mented processor programmed to calculate a change in
a light absorption caused by blood in the biological
sample and configured to receive the output photocur
rent signal from the at least one photocurrent signal

generating light detector and based on the received

output photocurrent signal, calculate the attenuance
30

Qi(C, 7) = _N [logA (ADC);]

tor , positioned to receive light from the at least one light

(39 )

attributable to blood in the biological sample present in
the target area , eliminate effect of uncertainty caused by
temperature dependent detector response of the at least
one photocurrent signal generating light detector by

calculating the standard deviation of a logarithm of the

v\logA(ADC) ]
35

time dependent voltage signal, and based on the cal
culated attenuance , determine a blood glucose level

associated with the biological sample present in the

The mathematic correlation between optical measurement

target area
and blood glucose concentration can then be established
2
.
The system for detecting glucose in a biological sample
according to Equation (19 ) or ( 20 ), under corresponding according
to claim 1, wherein the light absorbance change
calibration conditions .
Similar to normalization , the ratio factor defined by 40 determining algorithm implemented processor is configured
to calculate a normalization factor Q : CT
( ) based on the
Equation (21) can be expressed as :
output voltage Vi (t) of the ith preamplifier as a function of
time and standard deviation o according to the equation :

o [logA (ADC );]

Y;(C,T) = o[logA(ADC);]

(40)

The correlation between optical measurement and blood

A5

Q:(C,1)= 0[logV:(t)]
o [logV ;(0)]

glucose concentration can then be established according to

Equations (22 ) or (23 ), under corresponding calibration 50 wherein T is the temperature of the biological sample and C
conditions.
Thus, there has been shown and described several
embodiments of a novel invention . As is evident from the

is the concentration of blood glucose in the biological
sample .

3 . The system for detecting glucose in a biological sample
foregoing description , certain aspects of the present inven according
claim 1 , wherein the light absorbance change
tion are not limited by the particular details of the examples 55 determiningto algorithm
implemented processor is configured
illustrated herein , and it is therefore contemplated that other to calculate a ratio factor
Y , (C , T ) based on the output
modifications and applications, or equivalents thereof, will
voltage
Vi
(
t
)
of
the
ith
preamplifier
and V (t) of the jth
occur to those skilled in the art . The terms “ have," "having,”
as a function of time and standard deviation o
“ includes,” “ including," and similar terms as used in the preamplifier
foregoing specification are used in the sense of " optional ” or 604according to the equation :
“ may include” and not as “ required .” Many changes, modi

fications , variations and other uses and applications of the
present construction will, however, become apparent to

o?logV ;( )]

C; ) = o[logV;(d)]'

those skilled in the art after considering the specification and
the accompanying drawings. All such changes, modifica - 65
tions, variations and other uses and applications, which do wherein T is the temperature of the biological sample and C
not depart from the spirit and scope of the invention , are is concentration of blood glucose in the biological sample .

US 9 ,814 ,415 B2
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4 . The system for detecting glucose in a biological sample
according to claim 1, further comprising an analog -to -digital
convertor having a digitized voltage output.
5 . The system for detecting glucose in a biological sample
according to claim 4 , wherein the light absorbance change 5

mented processor by calculating the standard deviation

of a logarithm of the timedependent voltage signal ; and
determining a blood glucose level associated with the

biological sample present in the target area based on the
calculated attenuance with the light absorbance change
determining algorithm implemented processor.

determining algorithm implemented processor is configured
to calculate a normalization factor Q CT
( ) based on the

8 . The method for detecting glucose in a biological

voltage output A (ADC ); of the ith analog -to - digital con
verter, where a is standard deviation according to the equa

sample according to claim 7, further comprising calculating
a normalization factor Q :(C , T ) based on the voltage output
V (t) of the ith preamplifier as a function of time and
standard deviation o according to the equation :

tion :

Q :( C , T ) = o [logA (ADC);]

[logA (ADC);]

wherein T is the temperature of the biological sample and C
is the concentration of blood glucose in the biological
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Qi(C , T ) =

o [logV;(t)]

o [logV;(t)]

according to claim 4 , wherein the light absorbance change
determining algorithm implemented processor is configured
to calculate a ratio factor Y (CT) based on the voltage

wherein T is the temperature of the biological sample and C
20 is the concentration of blood glucose in the biological
sample.
9 . The method for detecting glucose in a biological
sample according to claim 7, further comprising calculating
a ratio factor Y . (C , T ) based on the output voltage Vi(t) of

voltage output A (ADC ); of the jth analog -to - digital conver -

function of time and standard deviation o according to the

tor, where o is standard deviation according to the equation :

equation:

sample .

6 . The system for detecting glucose in a biological sample

output A (ADC ); ofthe ith analog -to - digital convertor and the 25 the ith preamplifier and V (t) of the jth preamplifier as a

o [logA (ADC);]

30

o [logV;( )]

Y;j(C,T)= o[logV;(0)]'

Y;(C,T) = o[logA(ADC);]
wherein T is the temperature of the biological sample and

wherein T is the temperature of the biological sample and C

is the concentration of blood glucose in the biological 35 is the concentration of blood glucose in the biological
sample .
sample .

7 . A method for detecting glucose in a biological sample ,

10 . The method for detecting glucose in a biological

sample according to claim 7 , further comprising utilizing an
comprising:
utilizing at least one light beam generating structure
analog -to -digital convertor having a digitized voltage out
generates one or more light beams having a wavelength 40 put.
in a range between 800 nm and 1600 nm to strike a
11 . The method for detecting glucose in a biological
sample according to claim 10 , further comprising calculat
target area of a biological sample;

utilizing at least one photocurrent signal generating light ing a normalization factor Q (CT) based on the voltage
detector, which includes a preamplifier having a feed - as output A (ADC ); of the ith analog- to - digital convertor, where
back resistor, positioned to receive light from the at

a

is standard deviation according to the equation :

least one light source and generating an output photo
current signal, having a time dependent current, which
is indicative of the power of light detected ;

Q (C , T ) = o [logA (ADC);]

converting the time dependent current into a time depen - 50
Šo[logA (ADC);]
dent voltage signal with the preamplifier having a
feedback resistor;
receiving the output photocurrent signal from the at least wherein T is the temperature of the biological sample and C
one photocurrent signal generating light detector with a is the concentration of blood glucose in the biological
light absorbance change determining algorithm imple - 55 sample .
mented processor programmed to calculate a change in
12 . The method for detecting glucose in a biological
a light absorption caused by blood in the biological

sample according to claim 10 , further comprising calculat

sample and based on the received output photocurrent

ing a ratio factor Y (CT) based on the voltage output

signal,

A (ADC ); of the ith analog -to - digital convertor and the volt

calculating attenuance attributable to blood in the biologi- 60 age output A (ADC ); of the jth analog -to -digital convertor,
cal sample present in the target area with the light where a is standard deviation according to the equation :
absorbance change determining algorithm imple
mented processor ;

eliminating effect of uncertainty caused by temperature

dependent detector response of the at least one photo - 65
current signal generating light detector with the light
absorbance change determining algorithm imple

logA (ADC);]
Y;;(C , !1)! = oo [[logA
(ADC );]
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wherein T is the temperature of the biological sample and C
is the concentration of blood glucose in the biological
sample .

*

*

*

*

